Menu
Back to User profile » Dr Fatemeh Ahmadipour
Papers published by Dr Fatemeh Ahmadipour:
Inhibition of human prostate cancer (PC-3) cells and targeting of PC-3-derived prostate cancer stem cells with koenimbin, a natural dietary compound from Murraya koenigii (L) Spreng
Kamalidehghan B, Ghafouri-Fard S, Motevaseli E, Ahmadipour F
Drug Design, Development and Therapy 2018, 12:1119-1133
Published Date: 4 May 2018
Four novel ARSA gene mutations with pathogenic impacts on metachromatic leukodystrophy: a bioinformatics approach to predict pathogenic mutations
Dehghan Manshadi M, Kamalidehghan B, Aryani O, Khalili E, Dadgar S, Tondar M, Ahmadipour F, Yong Meng G, Houshmand M
Therapeutics and Clinical Risk Management 2017, 13:725-731
Published Date: 16 June 2017
Apoptotic induction and inhibition of NF-κB signaling pathway in human prostatic cancer PC3 cells by natural compound 2,2'-oxybis (4-allyl-1-methoxybenzene), biseugenol B, from Litsea costalis: an in vitro study
Abbaspour Babaei M, Zaman Huri H, Kamalidehghan B, Yeap SK, Ahmadipour F
OncoTargets and Therapy 2017, 10:277-294
Published Date: 10 January 2017
Receptor tyrosine kinase (c-Kit) inhibitors: a potential therapeutic target in cancer cells
Abbaspour Babaei M, Kamalidehghan B, Saleem M, Huri HZ, Ahmadipour F
Drug Design, Development and Therapy 2016, 10:2443-2459
Published Date: 1 August 2016
Association of nuclear and mitochondrial genes with audiological examinations in Iranian patients with nonaminoglycoside antibiotics-induced hearing loss
Balali M, Kamalidehghan B, Farhadi M, Ahmadipour F, Ashkezari MD, Hemami MR, Arabzadeh H, Falah M, Meng GY, Houshmand M
Therapeutics and Clinical Risk Management 2016, 12:117-128
Published Date: 28 January 2016
Synthesis, structural characterization, and anticancer activity of a monobenzyltin compound against MCF-7 breast cancer cells
Fani S, Kamalidehghan B, Lo KM, Hashim NM, Chow KM, Ahmadipour F
Drug Design, Development and Therapy 2015, 9:6191-6201
Published Date: 23 November 2015
Prevalence of the rs7903146C>T polymorphism in TCF7L2 gene for prediction of type 2 diabetes risk among Iranians of different ethnicities
Allahdini M, Kamalidehghan B, Akbari L, Azadfar P, Rahmani A, Ahmadipour F, Meng GY, Masserrat A, Houshmand M
Drug Design, Development and Therapy 2015, 9:5835-5841
Published Date: 28 October 2015
Prevalence of the CYP2D6*10 (C100T), *4 (G1846A), and *14 (G1758A) alleles among Iranians of different ethnicities
Bagheri A, Kamalidehghan B, Haghshenas M, Azadfar P, Akbari L, Sangtarash MH, Vejdandoust F, Ahmadipour F, Meng GY, Houshmand M
Drug Design, Development and Therapy 2015, 9:2627-2634
Published Date: 13 May 2015
Koenimbin, a natural dietary compound of Murraya koenigii (L) Spreng: inhibition of MCF7 breast cancer cells and targeting of derived MCF7 breast cancer stem cells (CD44+/CD24-/low): an in vitro study
Ahmadipour F, Noordin MI, Mohan S, Arya A, Paydar M, Looi CY, Keong YS, Siyamak EN, Fani S, Firoozi M, Yong CL, Sukari MA, Kamalidehghan B
Drug Design, Development and Therapy 2015, 9:1193-1208
Published Date: 24 February 2015